Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2003
11/20/2003US20030216380 Novel gamma secretase inhibitors
11/20/2003US20030216258 Condensed heterocylic compounds and herbicides containing them as active ingredients
11/20/2003US20030214228 Tricarbazolotriazines
11/20/2003US20030213164 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof
11/20/2003CA2485753A1 Benzimidazole derivatives
11/20/2003CA2485148A1 Pyrimidinone compounds, compositions and methods
11/20/2003CA2485083A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362856A1 Water-soluble triazole fungicide
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1265601B1 Method for treating ocular pain
11/19/2003EP0852226B1 Pyrimidine derivatives
11/19/2003EP0831811B1 Carbazoles for treating microbial infections
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003CN1128147C 3-oxo-2(H)-1,2,4-triazine deriatives as ligands of 5HT1A receptors
11/18/2003US6649770 Exhibit superior hydrolytic stability, handling and storage stability as well as good resistance to extractability when present in stabilized composition
11/18/2003US6649760 Substituted phenyluracils
11/18/2003US6649643 Imidazol-4-ylmehanols and their use as inhibitors of steroid C17-20 lyase
11/18/2003US6649642 Succinate derivative compounds useful as cysteine protease inhibitors
11/18/2003US6649634 Use in treating diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649620 Quinoline and quinazoline compounds useful in therapy
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649609 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649603 For therapy of metabolic disorders related to insulin resistance or hyperglycemia
11/18/2003US6649366 Methods and compositions related to modulators of annexin and cartilage homeostasis
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093281A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
11/13/2003WO2003093268A1 7-aminoimidazotriazones
11/13/2003WO2003093263A1 Substituted imidazole derivatives: gabaa receptor ligands
11/13/2003WO2003093262A2 Processes for preparing losartan and losartan potassium
11/13/2003WO2003093261A1 Phthalazinone derivatives
11/13/2003WO2003093260A1 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
11/13/2003WO2003093245A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003WO2003093244A1 Substituted (thioxo)carbonylamino phenyl uraciles
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003093235A1 Carboxylic acid amides
11/13/2003WO2003076417A3 Oxo-azabicyclic compounds
11/13/2003WO2003053344A3 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
11/13/2003WO2003041644A3 Method to treat cystic fibrosis
11/13/2003WO2003031407A3 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2003022806A3 Cbi analogues of cc-1065 and the duocarmycins
11/13/2003WO2003017939A3 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
11/13/2003WO2003015703A3 Compositions and methods relating to novel benzodiazepine compounds and targets thereof
11/13/2003WO2002016327A8 Benzimidazoles and analogues and their use as neutrophil inhibitors
11/13/2003US20030212269 Kinase inhibitor; antitumor agents, psoriasis, skin disorders, antiarthritic agents
11/13/2003US20030212121 Antiproliferative agents; anticancer agents; autoimmune diseases; cardiovascular disorders
11/13/2003US20030212120 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
11/13/2003US20030212119 Novel glucagon receptor antagonists/inverse agonists
11/13/2003US20030212117 Efficient process for the preparation of a factor Xa inhibitor
11/13/2003US20030212113 Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity
11/13/2003US20030212079 Antiischemic agents; central nervous system disorders
11/13/2003US20030212070 Dietetics; cardiovascular disorders; hypotensive agents; psychological disorders
11/13/2003US20030212066 1-Sulfonyl pyrrolidine derivatives
11/13/2003US20030212063 beta3 adrenergic receptor agonists
11/13/2003US20030212055 Cinnoline compounds
11/13/2003US20030212054 Therapy, prevention thrombosis; anticoagulant
11/13/2003US20030212012 Prevention labor contraction; urogenital disorders
11/13/2003CA2485093A1 Substituted imidazole derivatives: gabaa receptor ligands
11/13/2003CA2484280A1 Substituted (thioxo)carbonylamino phenyl uraciles
11/13/2003CA2484209A1 Protein kinase modulators and methods of use
11/13/2003CA2483865A1 7-aminoimidazotriazones
11/13/2003CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003CA2483566A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
11/13/2003CA2483532A1 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
11/13/2003CA2482857A1 Processes for preparing losartan and losartan potassium
11/13/2003CA2482806A1 Phthalazinone derivatives
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1361224A1 Heterocyclic hydrazones for use as anti-cancer agents
11/12/2003EP1361212A1 Peptide derivatives as antithrombotic agents
11/12/2003EP1359940A2 Combinations of statins, estrogenic agents and optionally estrogens
11/12/2003EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/12/2003EP1359913A1 Thrombin inhibitors
11/12/2003EP1242402B1 Novel compounds
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1007524B1 Indole derivatives as 5-ht1b and 5-ht1d agonists
11/12/2003EP0880509B1 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant-growth regulators
11/12/2003EP0861243B1 Heterocyclic compounds as bradykinin antagonists
11/12/2003EP0752987B1 Pyrimidinyl derivatives as interleukin inhibitors
11/12/2003CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists
11/12/2003CN1455769A Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
11/12/2003CN1127506C New compound for treating asgnodia
11/12/2003CN1127500C Substituted bisindolymaleimides for inhibition of cell proliferation
11/12/2003CN1127499C Novel form of irbesartan, Methods of obtaining said form and pharmaceutical compositions containing same
11/12/2003CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring
11/12/2003CN1127490C Cyclohexane derivatives difunctionalised in1,4 as ligands of 5-HT1A receptors
11/12/2003CN1127489C Fluorescent brightener
11/12/2003CN1127487C Phthalazinone and its use, and drug containing same
11/12/2003CN1127484C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation
11/11/2003US6646122 Ligand and complex for catalytically bleaching a substrate
1 ... 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 ... 626